Search company, investor...



Series C | Alive

Total Raised


Last Raised

$3.2M | 9 yrs ago

About Guangyintang

Manufacturer of traditional Chinese medicine. The company specializes in the R&D, production, sales, logistics, and import and export of traditional Chinese medicine, including preparation and extraction, pieces of Chinese medicine,health protecting food, the production and sales of the plant beverage, the Chinese medicinal herbs standardization research and GAP standardized planting, and electronic business. The business’s product offerings include Chinese herbal medicine, herbal extracts, herbal preparation, functional health beverage, and medical equipment.

Headquarters Location

1899 Yaodu Road



86 558 8108902

Missing: Guangyintang's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Guangyintang's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Guangyintang Frequently Asked Questions (FAQ)

  • What is Guangyintang's latest funding round?

    Guangyintang's latest funding round is Series C.

  • How much did Guangyintang raise?

    Guangyintang raised a total of $22.58M.

  • Who are the investors of Guangyintang?

    Investors of Guangyintang include Shenzhen GTJA Investment Group, ZhongheYida and Fuli Capital.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.